CURCUMIN: THE INDIAN SOLID GOLD

P1: OTE/SPH P2: OTE
SVNY332-Aggarwal December 22, 2006 16:34
20 AGGARWAL ET AL.
96. C. H. Park, E. R. Hahm, S. Park, H. K. Kim, and C. H. Yang, The inhibitory mechanism
of curcumin and its derivative against beta-catenin/Tcf signaling. FEBS Lett 579,
2965–2971 (2005).
97. M. M. Chan, Inhibition of tumor necrosis factor by curcumin, a phytochemical.
Biochem Pharmacol 49, 1551–1556 (1995).
98. M. K. Jang, D. H. Sohn, and J. H. Ryu, A curcuminoid and sesquiterpenes as inhibitors
of macrophage TNF-alpha release from Curcuma zedoaria. Planta Med 67, 550–552
(2001).
99. H. Matsuda, S. Tewtrakul, T. Morikawa, A. Nakamura, and M. Yoshikawa, Antiallergic
principles from Thai zedoary: structural requirements of curcuminoids for
inhibition of degranulation and effect on the release of TNF-alpha and IL-4 in RBL-
2H3 cells. Bioorg Med Chem 12, 5891–5898 (2004).
100. A. Gulcubuk, K. Altunatmaz, K. Sonmez, D. Haktanir-Yatkin, H. Uzun, A. Gurel and
S. Aydin, Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the
late phase of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin Med
53, 49–54 (2006).
101. J. P. Gaddipati, S. V. Sundar, J. Calemine, P. Seth, G. S. Sidhu, and R. K. Maheshwari,
Differential regulation of cytokines and transcription factors in liver by curcumin
following hemorrhage/resuscitation. Shock 19, 150–156 (2003).
102. C. J. Lee, J. H. Lee, J. H. Seok, G. M. Hur, Y. C. Park, I. C. Seol, and Y. H. Kim, Effects
of baicalein, berberine, curcumin and hesperidin on mucin release from airway goblet
cells. Planta Med 69, 523–526 (2003).
103. N. Jurrmann, R. Brigelius-Flohe and G. F. Bol, Curcumin blocks interleukin-1 (IL-1)
signaling by inhibiting the recruitment of the IL-1 receptor-associated kinase IRAK
in murine thymoma EL-4 cells. J Nutr 135, 1859–1864 (2005).
104. Y. Moon, W. C. Glasgow, and T. E. Eling, Curcumin suppresses interleukin 1betamediated
microsomal prostaglandin E synthase 1 by altering early growth response
gene 1 and other signaling pathways. J Pharmacol Exp Ther 315, 788–795 (2005).
105. M. Shakibaei, G. Schulze-Tanzil, T. John and A. Mobasheri, Curcumin protects human
chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin
expression and activation of caspase-3: An immunomorphological study. Ann Anat
187, 487–497 (2005).
106. T. Kobayashi, S. Hashimoto and T. Horie, Curcumin inhibition of Dermatophagoides
farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating
factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem
Pharmacol 54, 819–824 (1997).
107. Y. Abe, S. Hashimoto, and T. Horie, Curcumin inhibition of inflammatory cytokine
production by human peripheral blood monocytes and alveolar macrophages. Pharmacol
Res 39, 41–47 (1999).
108. H. Hidaka, T. Ishiko, T. Furuhashi, H. Kamohara, S. Suzuki, M. Miyazaki, O. Ikeda,
S. Mita, T. Setoguchi, and M. Ogawa, Curcumin inhibits interleukin 8 production and
enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic
carcinoma cell growth by autocrine regulation. Cancer 95, 1206–1214 (2002).
109. B. Y. Kang, S. W. Chung, W. Chung, S. Im, S. Y. Hwang, and T. S. Kim, Inhibition of
interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin.
Eur J Pharmacol 384, 191–195 (1999).
110. B. Y. Kang, Y. J. Song, K. M. Kim, Y. K. Choe, S. Y. Hwang and T. S. Kim, Curcumin
inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production
in macrophages. Br J Pharmacol 128, 380–384 (1999).